278 related articles for article (PubMed ID: 25599464)
1. Postoperative pro-adrenomedullin levels predict mortality in thoracic surgery patients: comparison with Acute Physiology and Chronic Health Evaluation IV Score*.
Schoe A; Schippers EF; Struck J; Ebmeyer S; Klautz RJ; de Jonge E; van Dissel JT
Crit Care Med; 2015 Feb; 43(2):373-81. PubMed ID: 25599464
[TBL] [Abstract][Full Text] [Related]
2. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study.
Christ-Crain M; Morgenthaler NG; Struck J; Harbarth S; Bergmann A; Müller B
Crit Care; 2005; 9(6):R816-24. PubMed ID: 16356231
[TBL] [Abstract][Full Text] [Related]
3. Predicting mortality after elective open-heart surgery using midregional-proadrenomedullin: is it time to scalp Acute Physiology and Chronic Health Evaluation IV?
Wu AH; Hale K
Crit Care Med; 2015 Feb; 43(2):494-5. PubMed ID: 25599481
[No Abstract] [Full Text] [Related]
4. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
Li ZH; Xiao J; Li JZ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951
[TBL] [Abstract][Full Text] [Related]
5. Mortality prediction after cardiac surgery: blood lactate is indispensible.
Badreldin AM; Doerr F; Elsobky S; Brehm BR; Abul-dahab M; Lehmann T; Bayer O; Wahlers T; Hekmat K
Thorac Cardiovasc Surg; 2013 Dec; 61(8):708-17. PubMed ID: 24338631
[TBL] [Abstract][Full Text] [Related]
6. Acute physiology and chronic health evaluation (APACHE II) scoring in a cardiothoracic intensive care unit.
Turner JS; Mudaliar YM; Chang RW; Morgan CJ
Crit Care Med; 1991 Oct; 19(10):1266-9. PubMed ID: 1914483
[TBL] [Abstract][Full Text] [Related]
7. Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Travaglino F; Russo V; De Berardinis B; Numeroso F; Catania P; Cervellin G; Nigra SG; Geraci F; Bressan MA; Guerrini S; Cavazza M; Folli C; Monzani V; Battista S; Mengozzi G; Noto P; Carpinteri G; Semplicini A; Stella F; Ingrassia S; Moscatelli P; Giuntini P; Salerno G; Cardelli P; Di Somma S
Am J Emerg Med; 2014 Apr; 32(4):334-41. PubMed ID: 24559907
[TBL] [Abstract][Full Text] [Related]
8. The acute physiology and chronic health evaluation III outcome prediction in patients admitted to the intensive care unit after pneumonectomy.
Keegan MT; Harrison BA; Brown DR; Whalen FX; Cassivi SD; Afessa B
J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):832-7. PubMed ID: 18068061
[TBL] [Abstract][Full Text] [Related]
9. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients.
Zimmerman JE; Kramer AA; McNair DS; Malila FM
Crit Care Med; 2006 May; 34(5):1297-310. PubMed ID: 16540951
[TBL] [Abstract][Full Text] [Related]
10. Quality of life before intensive care unit admission is a predictor of survival.
Hofhuis JG; Spronk PE; van Stel HF; Schrijvers AJ; Bakker J
Crit Care; 2007; 11(4):R78. PubMed ID: 17629906
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Mortality Probability Admission Model III, National Quality Forum, and Acute Physiology and Chronic Health Evaluation IV hospital mortality models: implications for national benchmarking*.
Kramer AA; Higgins TL; Zimmerman JE
Crit Care Med; 2014 Mar; 42(3):544-53. PubMed ID: 24158174
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients.
Cinar O; Cevik E; Acar A; Kaya C; Ardic S; Comert B; Yokusoglu M; Bilgi C; Meisner M; Madsen T
Am J Emerg Med; 2012 Nov; 30(9):1915-20. PubMed ID: 22742951
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
[TBL] [Abstract][Full Text] [Related]
14. Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak RM; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng LL; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Hartmann O; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2011 Aug; 58(10):1057-67. PubMed ID: 21867843
[TBL] [Abstract][Full Text] [Related]
15. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD.
Stolz D; Christ-Crain M; Morgenthaler NG; Miedinger D; Leuppi J; Müller C; Bingisser R; Struck J; Müller B; Tamm M
Chest; 2008 Aug; 134(2):263-272. PubMed ID: 18490402
[TBL] [Abstract][Full Text] [Related]
16. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study.
Soares M; Fontes F; Dantas J; Gadelha D; Cariello P; Nardes F; Amorim C; Toscano L; Rocco JR
Crit Care; 2004 Aug; 8(4):R194-203. PubMed ID: 15312218
[TBL] [Abstract][Full Text] [Related]
17. Performance evaluation of APACHE II score for an Indian patient with respiratory problems.
Gupta R; Arora VK
Indian J Med Res; 2004 Jun; 119(6):273-82. PubMed ID: 15243165
[TBL] [Abstract][Full Text] [Related]
18. Comparing observed and predicted mortality among ICUs using different prognostic systems: why do performance assessments differ?
Kramer AA; Higgins TL; Zimmerman JE
Crit Care Med; 2015 Feb; 43(2):261-9. PubMed ID: 25365725
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
[TBL] [Abstract][Full Text] [Related]
20. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
